Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.35), $0.03 better than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- RH (RH) Tops Q1 EPS by 12c
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
